Oncology & Hematology Coding Alert
Reader Question:
Factor in Adverse Effect Guidelines for Conditions Following Chemotherapy
Published on Wed Feb 28, 2018
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
Related Articles
Other Articles in this issue of
Oncology & Hematology Coding Alert
- CCI 24.0:
Prepare to Scratch Your Head at These Confusing Oncology Radiation Edits
New code 38222 means you no longer have to worry about this old edit. January [...] - MACRA:
Avoid a 4% Penalty — Report MIPS 2017 Data Before March 31
Remember you only need report 90 days of data for 2017 to sidestep penalties. Performance [...] - E/M:
Bust These 5 E/M Myths Before You Make Costly Mistakes
Do you know what counts as established? Find out. Coding advice can come from all [...] - Claims and Denials:
Make Certain Your Oncologists Sign Their Orders — Or Else
Don't waste your time appealing a denial due to a technicality. The Medicare Program Integrity [...] - You Be the Coder:
Malignant Neoplasm of Main Bronchus
Question: What changes can we anticipate for diagnosis coding for malignant bronchial neoplasms? Our physician [...] - Reader Question:
Delve Into The Difference Between Different PFSH
Question: Can you give me an example of pertinent PFSH versus complete PFSH? Florida Subscriber [...] - Reader Question:
Highlight Route for Ovarian Cyst Fluid Collection
Question: In a patient suspected to have ovarian tumor, our physician obtained a sample of [...] - Reader Question:
Factor in Adverse Effect Guidelines for Conditions Following Chemotherapy
Question: What ICD-10-CM code should I use for a consultation for vomiting following chemotherapy? Ohio [...]
View All
